• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠中进行不相容红细胞输血后,抗原密度决定红细胞清除,但不决定抗原调节。

Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.

作者信息

Arthur Connie M, Allen Jerry William L, Verkerke Hans, Yoo Justin, Jajosky Ryan P, Girard-Pierce Kathryn, Chonat Satheesh, Zerra Patricia, Maier Cheryl, Rha Jen, Fasano Ross, Josephson Cassandra D, Roback John D, Stowell Sean R

机构信息

Center for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and.

出版信息

Blood Adv. 2021 Jan 26;5(2):527-538. doi: 10.1182/bloodadvances.2020002695.

DOI:10.1182/bloodadvances.2020002695
PMID:33496748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7839377/
Abstract

Incompatible red blood cell (RBC) transfusion can result in life-threatening transfusion complications that can be challenging to manage in patients with transfusion-dependent anemia. However, not all incompatible RBC transfusions result in significant RBC removal. One factor that may regulate the outcome of incompatible RBC transfusion is the density of the incompatible antigen. Despite the potential influence of target antigen levels during incompatible RBC transfusion, a model system capable of defining the role of antigen density in this process has not been developed. In this study, we describe a novel model system of incompatible transfusion using donor mice that express different levels of the KEL antigen and recipients with varying anti-KEL antibody concentrations. Transfusion of KEL+ RBCs that express high or moderate KEL antigen levels results in rapid antibody-mediated RBC clearance. In contrast, relatively little RBC clearance was observed following the transfusion of KEL RBCs that express low KEL antigen levels. Intriguingly, unlike RBC clearance, loss of the KEL antigen from the transfused RBCs occurred at a similar rate regardless of the KEL antigen density following an incompatible transfusion. In addition to antigen density, anti-KEL antibody levels also regulated RBC removal and KEL antigen loss, suggesting that antigen density and antibody levels dictate incompatible RBC transfusion outcomes. These results demonstrate that antibody-induced antigen loss and RBC clearance can occur at distinct antigen density thresholds, providing important insight into factors that may dictate the outcome of an incompatible RBC transfusion.

摘要

不相容的红细胞(RBC)输血可导致危及生命的输血并发症,这对于依赖输血的贫血患者来说可能难以处理。然而,并非所有不相容的RBC输血都会导致大量RBC清除。一个可能调节不相容RBC输血结果的因素是不相容抗原的密度。尽管在不相容RBC输血过程中靶抗原水平有潜在影响,但尚未开发出一种能够确定抗原密度在此过程中作用的模型系统。在本研究中,我们描述了一种新型的不相容输血模型系统,使用表达不同水平KEL抗原的供体小鼠和具有不同抗KEL抗体浓度的受体。输注表达高或中等KEL抗原水平的KEL+RBC会导致抗体介导的RBC快速清除。相比之下,输注表达低KEL抗原水平的KEL RBC后,观察到的RBC清除相对较少。有趣的是,与RBC清除不同,无论不相容输血后KEL抗原密度如何,输注的RBC中KEL抗原的丢失速率相似。除了抗原密度外,抗KEL抗体水平也调节RBC清除和KEL抗原丢失,这表明抗原密度和抗体水平决定了不相容RBC输血的结果。这些结果表明,抗体诱导的抗原丢失和RBC清除可以在不同的抗原密度阈值下发生,这为可能决定不相容RBC输血结果的因素提供了重要的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1310/7839377/c80510f3edd2/advancesADV2020002695absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1310/7839377/c80510f3edd2/advancesADV2020002695absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1310/7839377/c80510f3edd2/advancesADV2020002695absf1.jpg

相似文献

1
Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.在小鼠中进行不相容红细胞输血后,抗原密度决定红细胞清除,但不决定抗原调节。
Blood Adv. 2021 Jan 26;5(2):527-538. doi: 10.1182/bloodadvances.2020002695.
2
Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen.补体成分 3 通过调节红细胞抗原负调控抗体反应。
Front Immunol. 2018 Jun 11;9:676. doi: 10.3389/fimmu.2018.00676. eCollection 2018.
3
Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice.储存方式会对小鼠输注后针对不同红细胞抗原的同种免疫产生差异影响。
Transfusion. 2023 Mar;63(3):457-462. doi: 10.1111/trf.17251. Epub 2023 Jan 27.
4
Antibody-mediated immune suppression by antigen modulation is antigen-specific.抗原调节介导的抗体免疫抑制具有抗原特异性。
Blood Adv. 2018 Nov 13;2(21):2986-3000. doi: 10.1182/bloodadvances.2018018408.
5
A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation.C3 在抗体诱导的红细胞清除和抗原调节中的新作用。
Blood. 2013 Sep 5;122(10):1793-801. doi: 10.1182/blood-2013-06-508952. Epub 2013 Jul 22.
6
Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.受者对一个 RBC 同种抗原的致敏直接增强了随后在小鼠中的同种免疫反应。
Blood Adv. 2018 Jan 23;2(2):105-115. doi: 10.1182/bloodadvances.2017010124.
7
Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion.边缘带 B 细胞在输血后诱导同种抗体形成。
Front Immunol. 2018 Nov 16;9:2516. doi: 10.3389/fimmu.2018.02516. eCollection 2018.
8
Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.表达人 KEL 糖蛋白的鼠红细胞输注可诱导具有临床意义的同种异体抗体。
Transfusion. 2014 Jan;54(1):179-89. doi: 10.1111/trf.12217. Epub 2013 Apr 29.
9
Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model.针对父系 RBC KEL 抗原的同种抗体可导致鼠类模型中的胎儿/新生儿溶血病。
Blood. 2013 Aug 22;122(8):1494-504. doi: 10.1182/blood-2013-03-488874. Epub 2013 Jun 25.
10
Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.抗原调节作为小鼠抗KEL免疫预防的潜在机制。
Blood. 2016 Dec 29;128(26):3159-3168. doi: 10.1182/blood-2016-06-724732. Epub 2016 Sep 29.

引用本文的文献

1
CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion.CD47在不相容输血后调节抗原调节和红细胞清除。
Front Immunol. 2025 Apr 4;16:1548548. doi: 10.3389/fimmu.2025.1548548. eCollection 2025.
2
Dynamics of antibody engagement of red blood cells and .红细胞抗体结合的动力学及…… (原文似乎不完整)
Front Immunol. 2024 Nov 28;15:1475470. doi: 10.3389/fimmu.2024.1475470. eCollection 2024.
3
ABO blood groups and galectins: Implications in transfusion medicine and innate immunity.

本文引用的文献

1
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease.依库珠单抗用于镰状细胞病中补体介导的血栓性微血管病
Haematologica. 2020 Dec 1;105(12):2887-2891. doi: 10.3324/haematol.2020.262006.
2
Role of complement in alloimmunization and hyperhemolysis.补体在同种免疫和过度溶血中的作用。
Curr Opin Hematol. 2020 Nov;27(6):406-414. doi: 10.1097/MOH.0000000000000610.
3
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.镰状细胞病中的溶血性输血反应:未得到充分重视且可能致命。
ABO 血型与半乳糖凝集素:在输血医学和天然免疫中的意义。
Semin Immunol. 2024 Jul-Sep;74-75:101892. doi: 10.1016/j.smim.2024.101892. Epub 2024 Oct 14.
4
Harnessing the potential of red blood cells in immunotherapy.挖掘红细胞在免疫治疗中的潜力。
Hum Immunol. 2024 Nov;85(6):111084. doi: 10.1016/j.humimm.2024.111084. Epub 2024 Sep 9.
5
Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.伴有意义未明抗体的小儿镰状细胞病患者输血后生物素标记红细胞生存研究。
Transfusion. 2024 May;64(5):800-807. doi: 10.1111/trf.17800. Epub 2024 Mar 20.
6
() Malaria: A Review & Proposal of Therapeutically Rational Exchange (T-REX) of -Resistant Red Blood Cells.()疟疾:抗药红细胞治疗性合理交换(T-REX)的综述与建议
Trop Med Infect Dis. 2023 Oct 20;8(10):478. doi: 10.3390/tropicalmed8100478.
7
Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression.抗体介导的抗原丢失开关增强了对抗体介导的免疫抑制的免疫反应。
Blood. 2023 Sep 21;142(12):1082-1098. doi: 10.1182/blood.2022018591.
8
Alloantigen Copy Number as a Critical Factor in RBC Alloimmunization.同种异体抗原拷贝数是 RBC 同种免疫的关键因素。
Transfus Med Rev. 2023 Jan;37(1):21-26. doi: 10.1016/j.tmrv.2022.12.009. Epub 2022 Dec 23.
9
ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies.ABO血型抗原与聚糖差异表达:关于常见人类酶缺陷进化的观点
iScience. 2022 Dec 14;26(1):105798. doi: 10.1016/j.isci.2022.105798. eCollection 2023 Jan 20.
10
Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice.预先免疫细胞内抗原可增强小鼠随后的红细胞同种免疫。
Blood. 2023 May 25;141(21):2642-2653. doi: 10.1182/blood.2022016588.
Haematologica. 2020 Mar;105(3):539-544. doi: 10.3324/haematol.2019.224709. Epub 2020 Feb 6.
4
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.美国血液学会 2020 年镰状细胞病指南:输血支持。
Blood Adv. 2020 Jan 28;4(2):327-355. doi: 10.1182/bloodadvances.2019001143.
5
Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.探讨补体在预测、预防和治疗溶血性输血反应中的作用。
Transfus Med Rev. 2019 Oct;33(4):217-224. doi: 10.1016/j.tmrv.2019.09.006. Epub 2019 Oct 18.
6
Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism.ABH 和 Lewis 组织血型抗原的生物学作用 第二部分:血栓形成、心血管疾病和代谢。
Vox Sang. 2019 Aug;114(6):535-552. doi: 10.1111/vox.12786. Epub 2019 May 14.
7
Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.了解 Fc 受体在炎症性疾病中的作用:从机制到新的治疗工具。
Front Immunol. 2019 Apr 12;10:811. doi: 10.3389/fimmu.2019.00811. eCollection 2019.
8
Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.预防和治疗与红细胞输血相关的溶血并发症所面临的挑战。
Transfus Clin Biol. 2019 May;26(2):130-134. doi: 10.1016/j.tracli.2019.03.002. Epub 2019 Mar 25.
9
Transfusion-related red blood cell alloantibodies: induction and consequences.输血相关红细胞同种抗体:诱导与后果。
Blood. 2019 Apr 25;133(17):1821-1830. doi: 10.1182/blood-2018-08-833962. Epub 2019 Feb 26.
10
Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcγ receptors in mice.在小鼠中,抗体介导的免疫抑制可能源于红细胞抗原丢失,且与Fcγ受体无关。
Transfusion. 2019 Jan;59(1):371-384. doi: 10.1111/trf.14939. Epub 2018 Nov 26.